Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

KCI, LifeCell and Systagenix to Form One Company Focused on Transformational Healing Solutions under the Leadership of President & CEO Joe Woody
CP Wire
Monday, September 30, 2013 - 11:09am
tags:
KCI, LifeCell, Systagenix, M&A, wound care, devices
Bumpy road won't deter Sanofi's push into emerging markets
Reuters
Monday, September 30, 2013 - 10:55am
tags:
Sanofi, emerging markets, China, M&A
Bard, Vaginal-Mesh Makers, Said to Be in Settlement Talks
Bloomberg
Monday, September 30, 2013 - 10:52am
tags:
vaginal mesh, Bard, devices
What's Left Of Enzon Pharmaceuticals?
Seeking Alpha
Monday, September 30, 2013 - 10:48am
tags:
Enzon
Achillion Falls on FDA Hold on Hepatitis C Medicine
Bloomberg
Monday, September 30, 2013 - 10:47am
tags:
Achillion, FDA, hepatitis C, sovaprevir
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease
Yahoo
Monday, September 30, 2013 - 10:45am
tags:
FDA, orphan drugs, Omeros, OMS824, Huntington's disease
Amgen's 10 Billion Dollar Molecule
Seeking Alpha
Monday, September 30, 2013 - 10:44am
tags:
Amgen, Takeda, ONYX Pharmaceuticals, Kyprolis
These 2 Hepatitis-C Drug Developers Are Getting Left in the Dust
Motley Fool
Monday, September 30, 2013 - 10:41am
tags:
hepatitis C, Vertex Pharmaceuticals, Incivek, sovaprevir, Achillion, IDX184, IDX320, Idenix
Biogen, Isis Pharma And The Attraction Of The Orphan Drug Business
Seeking Alpha
Monday, September 30, 2013 - 10:38am
tags:
Biogen Idec, Isis Pharmaceuticals, orphan drugs, Kynamro, ISIS-DMPKRx
US demand for biosimilarity testing growing says specialist CRO
Outsourcing Pharma
Monday, September 30, 2013 - 10:36am
tags:
CROs, biosimilars
Bayer Chastised For Nightcaps After A Medical Conference
Pharmalot
Monday, September 30, 2013 - 10:35am
tags:
Bayer
GlaxoSmithKline to divest thrombosis assets to Aspen
Yahoo/Fly on the Wall
Monday, September 30, 2013 - 10:34am
tags:
GSK, Aspen Group, thrombosis, Arixtra, Fraxiparine
AstraZeneca CEO gets two cheers after first year in job
Yahoo/Reuters
Monday, September 30, 2013 - 10:32am
tags:
Pharma CEOs, AstraZeneca, Pascal Soriot
Bayer appoints Pfizer's Brandicourt as head of healthcare
Yahoo/Reuters
Monday, September 30, 2013 - 10:32am
tags:
Bayer, Pfizer
With Promising Results, AstraZeneca Targets Mutated Lung Cancer And Rival Clovis Drug
TheStreet.com
Monday, September 30, 2013 - 10:31am
tags:
AZD9291, Clovis Oncology, AstraZeneca, CO-1686, non-small cell lung cancer
Indian pharma market isn’t going to be that rosy
The Hindu, India
Sunday, September 29, 2013 - 3:19pm
tags:
India
Drug, public interest groups split on compounding bill
The Hill
Sunday, September 29, 2013 - 3:17pm
tags:
compounding pharmacies
Hagens Berman: U.S. Judge Rejects Pharmaceutical Companies' Attempt to Dismiss Thalidomide Cases
Daily Finance
Sunday, September 29, 2013 - 3:16pm
tags:
thalidomide, GSK, Sanofi
Yervoy Battles Melanoma, but Can It Become a Blockbuster?
Motley Fool
Sunday, September 29, 2013 - 1:57pm
tags:
Yervoy, melanoma, Bristol-Myers Squibb
Why This Health Care Giant Can Be a Core Holding
Motley Fool
Sunday, September 29, 2013 - 1:56pm
tags:
JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.